<div id="readability-page-1"><ul><li>SeaStar Medical Holding Corp reported a quarterly adjusted loss of 90 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-5.50. The lone analyst forecast for the quarter was for a loss of 89 cents per share. </li><li>Revenue was $67.00 thousand​; analysts expected $150.00 thousand. </li><li>SeaStar Medical Holding Corp's reported EPS for the quarter was a loss of 90 cents​.</li><li>The company reported a quarterly loss of $4.42 million.</li><li>SeaStar Medical Holding Corp shares had risen by 25.3% this quarter.</li></ul>FORECAST CHANGES<ul><li>The mean earnings estimate of analysts was unchanged in the last three months.​ </li><li>In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</li></ul>RECOMMENDATIONS<ul><li>The current average analyst rating on the shares is &#34;buy&#34; and the breakdown of recommendations is 1 &#34;strong buy&#34; or &#34;buy,&#34; no &#34;hold&#34; and no &#34;sell&#34; or &#34;strong sell.&#34; The average consensus recommendation for the medical equipment, supplies &amp; distribution peer group is also &#34;buy&#34; </li><li>Wall Street's median 12-month price target for SeaStar Medical Holding Corp is $7.00 </li></ul>This summary was machine generated from LSEG data March 27 at 09:52 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)<div><table><tbody><tr><td>QUARTER ENDING</td><td>ESTIMATE </td><td>ACTUAL</td><td>BEAT, MET, MISSED</td></tr><tr><td>Dec. 31 2024 </td><td>-0.89</td><td>-0.90</td><td>Missed</td></tr><tr><td>Sep. 30 2024 </td><td>-1.13</td><td>-1.10</td><td>Beat</td></tr><tr><td>Jun. 30 2024 </td><td>-1.41</td><td>-1.03</td><td>Beat</td></tr><tr><td>Mar. 31 2024 </td><td>-3.75</td><td>-4.75</td><td>Missed</td></tr></tbody></table></div></div>

SeaStar Medical Holding Corp reported a quarterly adjusted loss of 90 cents per share for the quarter ended December 31, exceeding last year's loss of $5.50. Revenue was $67,000, below the expected $150,000. The company incurred a total loss of $4.42 million. Despite the losses, shares rose by 25.3% this quarter. Analysts maintain a "buy" rating, with a median 12-month price target of $7.00. No earnings estimate revisions occurred in the last 30 days.

SeaStar Medical Holding Corp reports results for the quarter ended December 31 - Earnings Summary